Who
Jasmine Kway
CEO - Singapore Volition
Company insider
Files Form 4 as: CEO - Singapore Volition, VolitionRX.
In numbers
- Trades disclosed
- 29
- Buys
- 1
- Sells
- 0
- Bought
- $6,000
- Sold
- $0
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 13 Apr 2020
- Last trade
- 26 Feb 2026
- Last filed
- 27 Feb 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 26 Feb 2026filed 27 Feb 2026 | VNRX VolitionRXDiagnostics & Labs | SEC FORM 4 Code A | —173,000 at $0.00 | filing |
| 26 Feb 2026filed 27 Feb 2026 | VNRX VolitionRXDiagnostics & Labs | SEC FORM 4 Code A | —173,000 at $0.00 | filing |
| 22 Jan 2026filed 23 Jan 2026 | VNRX VolitionRXDiagnostics & Labs | SEC FORM 4 Code A | —42,000 at $0.00 | filing |
| 22 Jan 2026filed 23 Jan 2026 | VNRX VolitionRXDiagnostics & Labs | SEC FORM 4 Code A | —42,000 at $0.00 | filing |
| 15 Aug 2025filed 19 Aug 2025 | VNRX VolitionRXDiagnostics & Labs | SEC FORM 4 Code A | —12,507 at $0.00 | filing |
| 1 Jun 2025filed 3 Jun 2025 | VNRX VolitionRXDiagnostics & Labs | SEC FORM 4 Code A | —8,327 at $0.00 | filing |
| 1 Mar 2025filed 4 Mar 2025 | VNRX VolitionRXDiagnostics & Labs | SEC FORM 4 Code A | —16,708 at $0.00 | filing |
| 29 Jan 2025filed 31 Jan 2025 | VNRX VolitionRXoption or derivative · Diagnostics & Labs | SEC FORM 4 Code D | —50,000 | filing |
| 29 Jan 2025filed 31 Jan 2025 | VNRX VolitionRXoption or derivative · Diagnostics & Labs | SEC FORM 4 Code A | —50,000 | filing |
| 1 Dec 2024filed 3 Dec 2024 | VNRX VolitionRXDiagnostics & Labs | SEC FORM 4 Code A | —15,169 at $0.00 | filing |
| 1 Sep 2024filed 4 Sep 2024 | VNRX VolitionRXDiagnostics & Labs | SEC FORM 4 Code A | —15,668 at $0.00 | filing |
| 15 Aug 2024filed 16 Aug 2024 | VNRX VolitionRXDiagnostics & Labs | SEC FORM 4 Code A | —16,750 at $0.00 | filing |
| 1 Jun 2024filed 4 Jun 2024 | VNRX VolitionRXDiagnostics & Labs | SEC FORM 4 Code A | —13,570 at $0.00 | filing |
| 24 Jan 2024filed 26 Jan 2024 | VNRX VolitionRXDiagnostics & Labs | SEC FORM 4 Code A | —28,475 at $0.00 | filing |
| 24 Aug 2023filed 25 Aug 2023 | VNRX VolitionRXDiagnostics & Labs | SEC FORM 4 Bought | $6,0005,000 at $1.20 | filing |
| 5 Jul 2023filed 7 Jul 2023 | VNRX VolitionRXDiagnostics & Labs | SEC FORM 4 Code A | —22,050 at $0.00 | filing |
| 12 Jan 2023filed 13 Jan 2023 | VNRX VolitionRXDiagnostics & Labs | SEC FORM 4 Code A | —18,375 at $0.00 | filing |
| 13 Oct 2022filed 14 Oct 2022 | VNRX VolitionRXDiagnostics & Labs | SEC FORM 4 Code A | —8,575 at $0.00 | filing |
| 23 Jun 2022filed 24 Jun 2022 | VNRX VolitionRXoption or derivative · Diagnostics & Labs | SEC FORM 4 Code A | —32,869 at $0.00 | filing |
| 23 Jun 2022filed 24 Jun 2022 | VNRX VolitionRXDiagnostics & Labs | SEC FORM 4 Code A | —17,836 at $0.00 | filing |
News
No headline names them, or the companies they trade most, lately.